feed,title,long_url,short_url
Investing,Obesity drug supply delay not unusual says Novo Nordisk CEO,https://investing.com/news/-2863105,
Investing,Next Says Q2 Full-Price Sales Stronger Than Expected,https://investing.com/news/-2863083,
